BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 23957733)

  • 21. V(D)J-mediated translocations in lymphoid neoplasms: a functional assessment of genomic instability by cryptic sites.
    Marculescu R; Le T; Simon P; Jaeger U; Nadel B
    J Exp Med; 2002 Jan; 195(1):85-98. PubMed ID: 11781368
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chromosomal translocations in lymphoid neoplasia: a reappraisal of the recombinase model.
    Tycko B; Sklar J
    Cancer Cells; 1990 Jan; 2(1):1-8. PubMed ID: 2201335
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Induction of V(D)J-mediated recombination of an extrachromosomal substrate following exposure to DNA-damaging agents.
    Pinsonneault RL; Vacek PM; O'Neill JP; Finette BA
    Environ Mol Mutagen; 2007 Jul; 48(6):440-50. PubMed ID: 17584881
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inversions produced during V(D)J rearrangement at IgH, the immunoglobulin heavy-chain locus.
    Sollbach AE; Wu GE
    Mol Cell Biol; 1995 Feb; 15(2):671-81. PubMed ID: 7823936
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Heterogeneous breakpoints on the immunoglobulin genes are involved in fusion with the 5' region of BCL2 in B-cell tumors.
    Yonetani N; Ueda C; Akasaka T; Nishikori M; Uchiyama T; Ohno H
    Jpn J Cancer Res; 2001 Sep; 92(9):933-40. PubMed ID: 11572760
    [TBL] [Abstract][Full Text] [Related]  

  • 26. V(D)J recombinase-mediated HPRT mutations in peripheral blood lymphocytes of normal children.
    Finette BA; Poseno T; Albertini RJ
    Cancer Res; 1996 Mar; 56(6):1405-12. PubMed ID: 8640832
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A V(D)J recombinase-inducible B-cell line: role of transcriptional enhancer elements in directing V(D)J recombination.
    Oltz EM; Alt FW; Lin WC; Chen J; Taccioli G; Desiderio S; Rathbun G
    Mol Cell Biol; 1993 Oct; 13(10):6223-30. PubMed ID: 8413222
    [TBL] [Abstract][Full Text] [Related]  

  • 28. RAG-1 and RAG-2, adjacent genes that synergistically activate V(D)J recombination.
    Oettinger MA; Schatz DG; Gorka C; Baltimore D
    Science; 1990 Jun; 248(4962):1517-23. PubMed ID: 2360047
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of mutagenic V(D)J recombinase mediated mutations at the HPRT locus as an in vivo model for studying rearrangements with leukemogenic potential in children.
    Finette BA
    DNA Repair (Amst); 2006 Sep; 5(9-10):1049-64. PubMed ID: 16807138
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Germline DNA Retention in Murine and Human Rearranged T Cell Receptor Gene Coding Joints: Alternative Recombination Signal Sequences and V(D)J Recombinase Errors.
    Mika J; Kabacik S; Badie C; Polanska J; Candéias SM
    Front Immunol; 2019; 10():2637. PubMed ID: 31781122
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of DNA surrounding the breakpoints of chromosomal translocations involving the beta T cell receptor gene in human lymphoblastic neoplasms.
    Reynolds TC; Smith SD; Sklar J
    Cell; 1987 Jul; 50(1):107-17. PubMed ID: 3036364
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Roles of nonhomologous DNA end joining, V(D)J recombination, and class switch recombination in chromosomal translocations.
    Lieber MR; Yu K; Raghavan SC
    DNA Repair (Amst); 2006 Sep; 5(9-10):1234-45. PubMed ID: 16793349
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dual role of RAG2 in V(D)J recombination: catalysis and regulation of ordered Ig gene assembly.
    Kirch SA; Rathbun GA; Oettinger MA
    EMBO J; 1998 Aug; 17(16):4881-6. PubMed ID: 9707447
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alternative end-joining in follicular lymphomas' t(14;18) translocation.
    Marculescu R; Le T; Böcskör S; Mitterbauer G; Chott A; Mannhalter C; Jaeger U; Nadel B
    Leukemia; 2002 Jan; 16(1):120-6. PubMed ID: 11840271
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quantification of hprt gene deletions mediated by illegitimate V(D)J recombination in peripheral blood cells of humans.
    Fuscoe JC; Vira LK; Collard DD; Moore MM
    Environ Mol Mutagen; 1997; 29(1):28-35. PubMed ID: 9020304
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular mechanism of the t(14;18)--a model for lymphoid-specific chromosomal translocations.
    Jaeger U; Karth GD; Knapp S; Friedl J; Laczika K; Kusec R
    Leuk Lymphoma; 1994 Jul; 14(3-4):197-202. PubMed ID: 7950908
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alternating purine-pyrimidine tracts may promote chromosomal translocations seen in a variety of human lymphoid tumours.
    Boehm T; Mengle-Gaw L; Kees UR; Spurr N; Lavenir I; Forster A; Rabbitts TH
    EMBO J; 1989 Sep; 8(9):2621-31. PubMed ID: 2531086
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Disruption of the multiple tumor suppressor gene MTS1/p16(INK4a)/CDKN2 by illegitimate V(D)J recombinase activity in T-cell acute lymphoblastic leukemias.
    Cayuela JM; Gardie B; Sigaux F
    Blood; 1997 Nov; 90(9):3720-6. PubMed ID: 9345058
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Templated nucleotide addition and immunoglobulin JH-gene utilization in t(11;14) junctions: implications for the mechanism of translocation and the origin of mantle cell lymphoma.
    Welzel N; Le T; Marculescu R; Mitterbauer G; Chott A; Pott C; Kneba M; Du MQ; Kusec R; Drach J; Raderer M; Mannhalter C; Lechner K; Nadel B; Jaeger U
    Cancer Res; 2001 Feb; 61(4):1629-36. PubMed ID: 11245476
    [TBL] [Abstract][Full Text] [Related]  

  • 40. V(D)J targeting mistakes occur at low frequency in acute lymphoblastic leukemia.
    Vanura K; Vrsalovic MM; Le T; Marculescu R; Kusec R; Jäger U; Nadel B
    Genes Chromosomes Cancer; 2009 Aug; 48(8):725-36. PubMed ID: 19455608
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.